萘呋胺酯草酸鹽
|
|
|
- CAS號(hào):
- 3200-06-4
- 英文名:
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- 英文別名:
- ls121;Iridus;eu-1806;CLARANTIN;Acid oxalate;NAFRONYL OXALATE;naftidrofuryloxalate;Nafronyl acid oxalate;hylester,oxalate(1:1);NAFRONYL OXALATE SALT
- 中文名:
- 萘呋胺酯草酸鹽
- 中文別名:
- 萘呋胺酯;草酸萘呋胺;萘呋胺草酸鹽;草酸萘呋胺氫;萘呋胺酯草酸鹽;硝基呋喃草酸氫鹽;萘呋胺酯草酸鹽 標(biāo)準(zhǔn)品;萘呋胺酯 草酸鹽,10 MM DMSO 溶液;Α-(1-萘基甲基)-2-四氫呋喃丙酸二乙氨基乙酯;Α-(1-萘甲基)-2-四氫呋喃丙酸二乙胺基乙基酯草酸鹽
- CBNumber:
- CB5426302
- 分子式:
- C26H35NO7
- 分子量:
- 473.56
- MOL File:
- 3200-06-4.mol
|
|
|
萘呋胺酯草酸鹽化學(xué)性質(zhì)
-
熔點(diǎn):
-
110-111°
-
|
-
沸點(diǎn):
-
574°C (rough estimate)
-
|
-
密度:
-
1.2205 (rough estimate)
-
|
-
折射率:
-
1.6000 (estimate)
-
|
-
儲(chǔ)存條件:
-
Store at -20°C
-
|
-
溶解度:
-
Freely soluble in water, freely soluble or soluble in ethanol (96 per cent), slightly or sparingly soluble in acetone.
-
|
-
形態(tài):
-
Solid
-
|
-
顏色:
-
White to off-white
-
|
萘呋胺酯草酸鹽性質(zhì)、用途與生產(chǎn)工藝
萘呋胺酯草酸鹽為有機(jī)酸物質(zhì)，其是腦血管和外周血管的擴(kuò)張劑；拮抗5-羥色胺及緩激肽的作用；可使細(xì)胞內(nèi)ATP增多以改善細(xì)胞代謝；降低血液及血漿的粘稠度及纖維蛋白原濃度；增加細(xì)胞的氧化能力，對(duì)細(xì)胞缺氧具保護(hù)作用；此外具有罌粟堿樣的解痙作用，緩慢而持久。
萘呋胺酯草酸鹽是一種用于治療心腦血管與周圍血管疾病的藥物，具有如下特點(diǎn)：其擴(kuò)張作用比煙酸強(qiáng)，增強(qiáng)腦血管流量的作用較罌粟緩慢而持久。據(jù)認(rèn)為其臨床應(yīng)用比罌粟堿安全，對(duì)嚴(yán)重下肢動(dòng)脈炎的療效較煙胺羥丙茶堿顯著而迅速。
萘呋胺酯草酸鹽是一種用于治療心腦血管與周圍血管疾病的藥物。其具有如下特點(diǎn)：其擴(kuò)張作用比煙酸強(qiáng)，增強(qiáng)腦血管流量的作用較罌粟緩慢而持久。
Naftidrofuryl oxalate (Nafronyl oxalate salt) 是在外周血和腦血管病癥如血管擴(kuò)張藥的管理中使用的藥物, 增加細(xì)胞氧化能力, 且是一種 5-HT2 受體拮抗劑。
| Target | Value |
5-HT2 receptor
()
|
Naftidrofuryl oxalate (Nafronyl oxalate salt) may be effective for relieving the pain of muscle cramps.
Naftidrofuryl oxalate (Nafronyl oxalate salt) is the only vasoactive drug for peripheral arterial disease (PAD) which is likely to be cost-effective.
Naftidrofuryl oxalate (Nafronyl oxalate salt) is ranked first for both maximum walking distance (MWD) and pain-free walking distance (PFWD) (probability of 0·947 and 0·987, respectively, of being the best treatment) followed by cilostazol and pentoxifylline. Naftidrofuryl oxalate (Nafronyl oxalate salt) is effective treatments for claudication, Naftidrofuryl oxalate is likely to be the most effective, with minimal serious adverse events.
萘呋胺酯草酸鹽
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS編號(hào) | 包裝 | 價(jià)格 |
|---|
| 2025/02/08 | HY-B1107 | 萘呋胺酯草酸鹽
Naftidrofuryl oxalate | 3200-06-4 | 100mg | 500元 |
| 2025/02/08 | HY-B1107 | 萘呋胺酯草酸鹽
Naftidrofuryl oxalate | 3200-06-4 | 10mM * 1mLin DMSO | 550元 |
3200-06-4, 萘呋胺酯草酸鹽 相關(guān)搜索:
- CASODEX
- 抑制劑
- 藥靶配體
- 原料藥
- 化工原料
- 醫(yī)藥原料
- 小分子抑制劑
- Alphabetic
- Analytical Chromatography Product Catalog
- Analytical Standards
- NA - NI
- C26H34NO7
- C24H33NO3C2H2O4
- 萘呋胺酯 草酸鹽,10 MM DMSO 溶液
- 2-(二乙基氨基)乙基 3-(萘-1-基)-2-((四氫呋喃-2-基)甲基)丙酸酯 草酸鹽
- 硝基呋喃草酸氫鹽
- 萘呋胺草酸鹽
- 草酸萘呋胺氫
- 萘呋胺酯草酸鹽 標(biāo)準(zhǔn)品
- 萘呋胺酯草酸鹽
- 草酸萘呋胺
- alpha-(1-萘甲基)-2-四氫呋喃丙酸二乙胺基乙基酯草酸鹽
- Α-(1-萘基甲基)-2-四氫呋喃丙酸二乙氨基乙酯
- Α-(1-萘甲基)-2-四氫呋喃丙酸二乙胺基乙基酯草酸鹽
- 萘呋胺酯
- 3200-06-4
- Naftidrofuryl oxalate, 10 mM in DMSO
- 2-Furanpropanoic acid, tetrahydro-a-(1-naphthalenylmethyl)-,2-(diethylamino)ethyl ester, ethanedioate (1:1)
- 5-hydroxytryptamine Receptor,Inhibitor,Naftidrofuryl oxalate,Serotonin Receptor,Naftidrofuryl,inhibit,5-HT Receptor,Nafronyl
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate USP/EP/BP
- Nafronyl oxalate salt USP/EP/BP
- Acid oxalate
- α-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- Nafronyl oxalate salt ,98%
- Nafronyl oxalate salt ,99%
- 2-(DiethylaMino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)Methyl)propanoate oxalate
- Nafronyl oxalate salt ,96%
- Iridus
- 2-Furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl esteroxalate (1:1)
- 2-Furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl ester oxalate (1:1)
- 2-Furanpropanoic acid, tetrahydro-.alpha.-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester, ethanedioate (1:1)
- 2-(Diethylamino)ethyl tetrahydro-.alpha.-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1)
- NAFRONYL OXALATE SALT
- NAFRONYL OXALATE
- ALPHA-[1-NAPHTHYLMETHYL]-2-TETRAHYDROFURANPROPIONIC ACID DIETHYLAMINOETHYL ESTER OXALATE SALT
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- α-(1-naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester
- Nafronyl acid oxalate
- CLARANTIN
- diethyl[2-[2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy]ethyl]ammonium hydrogen oxalate
- naftidrofuryloxalate
- ls121
- hylester,oxalate(1:1)
- eu-1806
- 2-(diethylamino)ethyltetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionateo